Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cancer pathways. Its structure supports binding to specific enzyme active sites, making it valuable in developing targeted therapies. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) for oncology drugs, especially in modulating signaling proteins involved in cell proliferation. Also utilized in structure-activity relationship (SAR) studies to optimize drug potency and selectivity.